A critical systematic review of extracellular vesicle clinical trials
Abstract This systematic review examines the landscape of extracellular vesicle (EV)‐related clinical trials to elucidate the field's trends in clinical applications and EV‐related methodologies, with an additional focus on the acknowledgement of EV subpopulations. By analysing data from public...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Journal of Extracellular Vesicles |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jev2.12510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846118076492283904 |
|---|---|
| author | Rachel R. Mizenko Madison Feaver Batuhan T. Bozkurt Neona Lowe Bryan Nguyen Kuan‐Wei Huang Aijun Wang Randy P. Carney |
| author_facet | Rachel R. Mizenko Madison Feaver Batuhan T. Bozkurt Neona Lowe Bryan Nguyen Kuan‐Wei Huang Aijun Wang Randy P. Carney |
| author_sort | Rachel R. Mizenko |
| collection | DOAJ |
| description | Abstract This systematic review examines the landscape of extracellular vesicle (EV)‐related clinical trials to elucidate the field's trends in clinical applications and EV‐related methodologies, with an additional focus on the acknowledgement of EV subpopulations. By analysing data from public reporting repositories, we catalogued 471 EV‐related clinical trials to date, with indications for over 200 diseases. Diagnostics and companion diagnostics represented the bulk of EV‐related clinical trials with cancer being the most frequent application. EV‐related therapeutics trials mainly utilized mesenchymal stromal cell (MSC) EVs and were most frequently used for treatment of respiratory illnesses. Ultracentrifugation and RNA‐sequencing were the most common isolation and characterization techniques; however, methodology for each was not frequently reported in study records. Most of the reported characterization relied on bulk characterization of EV isolates, with only 11% utilizing EV subpopulations in their experimental design. While this may be connected to a lack of available techniques suitable for clinical implementation, it also highlights the opportunity for use of EV subpopulations to improve translational efforts. As academic research identifies more chemically distinct subpopulations and technologies for their enrichment, we forecast to more refined EV trials in the near future. This review emphasizes the need for meticulous methodological reporting and consideration of EV subpopulations to enhance the translational success of EV‐based interventions, pointing towards a paradigm shift in personalized medicine. |
| format | Article |
| id | doaj-art-9a3e8f2b68ae452097cfeb344d7646c5 |
| institution | Kabale University |
| issn | 2001-3078 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Extracellular Vesicles |
| spelling | doaj-art-9a3e8f2b68ae452097cfeb344d7646c52024-12-18T07:26:41ZengWileyJournal of Extracellular Vesicles2001-30782024-10-011310n/an/a10.1002/jev2.12510A critical systematic review of extracellular vesicle clinical trialsRachel R. Mizenko0Madison Feaver1Batuhan T. Bozkurt2Neona Lowe3Bryan Nguyen4Kuan‐Wei Huang5Aijun Wang6Randy P. Carney7Department of Biomedical Engineering University of California Davis California USADepartment of Biomedical Engineering University of California Davis California USADepartment of Biomedical Engineering University of California Davis California USADepartment of Biomedical Engineering University of California Davis California USADepartment of Biomedical Engineering University of California Davis California USADepartment of Biomedical Engineering University of California Davis California USADepartment of Biomedical Engineering University of California Davis California USADepartment of Biomedical Engineering University of California Davis California USAAbstract This systematic review examines the landscape of extracellular vesicle (EV)‐related clinical trials to elucidate the field's trends in clinical applications and EV‐related methodologies, with an additional focus on the acknowledgement of EV subpopulations. By analysing data from public reporting repositories, we catalogued 471 EV‐related clinical trials to date, with indications for over 200 diseases. Diagnostics and companion diagnostics represented the bulk of EV‐related clinical trials with cancer being the most frequent application. EV‐related therapeutics trials mainly utilized mesenchymal stromal cell (MSC) EVs and were most frequently used for treatment of respiratory illnesses. Ultracentrifugation and RNA‐sequencing were the most common isolation and characterization techniques; however, methodology for each was not frequently reported in study records. Most of the reported characterization relied on bulk characterization of EV isolates, with only 11% utilizing EV subpopulations in their experimental design. While this may be connected to a lack of available techniques suitable for clinical implementation, it also highlights the opportunity for use of EV subpopulations to improve translational efforts. As academic research identifies more chemically distinct subpopulations and technologies for their enrichment, we forecast to more refined EV trials in the near future. This review emphasizes the need for meticulous methodological reporting and consideration of EV subpopulations to enhance the translational success of EV‐based interventions, pointing towards a paradigm shift in personalized medicine.https://doi.org/10.1002/jev2.12510diagnosticsdrug delivery vehiclesexosomesheterogeneitytherapeutics |
| spellingShingle | Rachel R. Mizenko Madison Feaver Batuhan T. Bozkurt Neona Lowe Bryan Nguyen Kuan‐Wei Huang Aijun Wang Randy P. Carney A critical systematic review of extracellular vesicle clinical trials Journal of Extracellular Vesicles diagnostics drug delivery vehicles exosomes heterogeneity therapeutics |
| title | A critical systematic review of extracellular vesicle clinical trials |
| title_full | A critical systematic review of extracellular vesicle clinical trials |
| title_fullStr | A critical systematic review of extracellular vesicle clinical trials |
| title_full_unstemmed | A critical systematic review of extracellular vesicle clinical trials |
| title_short | A critical systematic review of extracellular vesicle clinical trials |
| title_sort | critical systematic review of extracellular vesicle clinical trials |
| topic | diagnostics drug delivery vehicles exosomes heterogeneity therapeutics |
| url | https://doi.org/10.1002/jev2.12510 |
| work_keys_str_mv | AT rachelrmizenko acriticalsystematicreviewofextracellularvesicleclinicaltrials AT madisonfeaver acriticalsystematicreviewofextracellularvesicleclinicaltrials AT batuhantbozkurt acriticalsystematicreviewofextracellularvesicleclinicaltrials AT neonalowe acriticalsystematicreviewofextracellularvesicleclinicaltrials AT bryannguyen acriticalsystematicreviewofextracellularvesicleclinicaltrials AT kuanweihuang acriticalsystematicreviewofextracellularvesicleclinicaltrials AT aijunwang acriticalsystematicreviewofextracellularvesicleclinicaltrials AT randypcarney acriticalsystematicreviewofextracellularvesicleclinicaltrials AT rachelrmizenko criticalsystematicreviewofextracellularvesicleclinicaltrials AT madisonfeaver criticalsystematicreviewofextracellularvesicleclinicaltrials AT batuhantbozkurt criticalsystematicreviewofextracellularvesicleclinicaltrials AT neonalowe criticalsystematicreviewofextracellularvesicleclinicaltrials AT bryannguyen criticalsystematicreviewofextracellularvesicleclinicaltrials AT kuanweihuang criticalsystematicreviewofextracellularvesicleclinicaltrials AT aijunwang criticalsystematicreviewofextracellularvesicleclinicaltrials AT randypcarney criticalsystematicreviewofextracellularvesicleclinicaltrials |